Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Zacks Investment Research on MSN1d
Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More
Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after Bristol Myers Squibb BMY ...
Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Stake Cut by US Bancorp DE
US Bancorp DE cut its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 14.0% during the ...
What is HC Wainwright’s Forecast for CDTX FY2029 Earnings?
Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...
Investor's Business Daily on MSN3d
Dow Jones Slides 400 Points On New Trump Tariffs; Nvidia, Palantir, Tesla Rally
The Dow Jones fell 270 points Tuesday after Monday's market sell-off. Nvidia, Palantir and Tesla rebounded on the stock ...
GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule
GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, ...
GRI Bio regains compliance with Nasdaq minimum bid price rule
GRI Bio (GRI) received notice on March 10, 2025 from The Nasdaq Stock Market stating that the Company regained compliance with Nasdaq Listing ...
Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter ...
Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Keith Speights has positions in Amazon and Vertex Pharmaceuticals. The Motley ...
BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat
The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...
Bank of New York Mellon Corp Buys 147,748 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Bank of New York Mellon Corp grew its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 10.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned ...